Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Immune Surveillance by NK Cells and Phagocytes

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clearance of Senescent Cells by BCL<sub>XL</sub>-PROTAC: A Novel Approach to Treat COPD?

Aging cell·2026

Same author

Single-cell microfluidic quantification of miRNA-21 and miRNA-34a reveals miRNA interactions in small airway epithelial cells and fibroblasts from patients with COPD.

American journal of physiology. Lung cellular and molecular physiology·2026

Same author

Catalogue of LPS-induced transcriptional changes across vertebrates identifies syntenically conserved human long non-coding RNAs that regulate the innate immune response.

Frontiers in immunology·2026

Same author

Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice.

Frontiers in medicine·2025

Same author

Chronic Obstructive Pulmonary Disease Airway Epithelial Cell-derived Extracellular Vesicles Spread Cellular Senescence via MicroRNA-34a.

American journal of respiratory cell and molecular biology·2025

Same author

Identification of an emphysema-specific ATII cell: a step towards understanding impaired lung regeneration in COPD?

The European respiratory journal·2024

Search research articles

Related Experiment Video

Updated: Jun 10, 2025

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

Macrophage Dysfunction in Respiratory Disease.

Shyreen Hassibi¹, Louise E Donnelly²

¹Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.

Results and Problems in Cell Differentiation

|October 15, 2024

Summary

Pulmonary macrophages are crucial for lung health, but become dysfunctional in lung diseases like COPD and asthma. Understanding these changes may lead to new targeted therapies for debilitating respiratory conditions.

Keywords:

Alveolar macrophages Asthma COPD Cystic fibrosis IPF

More Related Videos

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

Related Experiment Videos

Last Updated: Jun 10, 2025

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

Area of Science:

Pulmonary immunology and cell biology
Respiratory medicine and disease pathology

Background:

Pulmonary macrophages are key immune cells in the lung, essential for maintaining homeostasis by clearing pathogens and apoptotic cells.
Lung diseases, including COPD, asthma, cystic fibrosis, and IPF, affect millions globally and are characterized by aberrant macrophage function.
Dysfunctional macrophages in lung disease exhibit reduced phagocytosis and a pro-inflammatory phenotype, impairing their ability to resolve inflammation.

Purpose of the Study:

To review recent advancements in understanding pulmonary macrophage origin, phenotype, and function.
To explore the role of macrophages in lung homeostasis and disease pathogenesis.
To highlight the metabolic and mitochondrial changes contributing to macrophage dysfunction in lung diseases.

Main Methods:

Lineage tracing studies
Single-cell RNA sequencing
Review of existing literature on lung disease and macrophage biology

Main Results:

Pulmonary macrophages play vital roles in lung homeostasis, pathogen clearance, and inflammation resolution.
Lung diseases are associated with significant alterations in macrophage phenotype, including reduced phagocytic capacity and increased inflammation.
Metabolic and mitochondrial dysregulation are common features contributing to pro-inflammatory macrophage phenotypes in various lung conditions.

Conclusions:

Pulmonary macrophages are central to lung health and disease.
Aberrant macrophage function, driven by disease-specific environmental factors and metabolic changes, contributes to lung disease progression.
Targeting the mechanisms driving macrophage dysfunction holds promise for developing novel therapies for chronic lung diseases.